company background image
BCPC logo

Balchem NasdaqGS:BCPC Stock Report

Last Price

US$143.48

Market Cap

US$4.6b

7D

-3.0%

1Y

11.5%

Updated

20 Apr, 2024

Data

Company Financials +

BCPC Stock Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.

BCPC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Balchem Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Balchem
Historical stock prices
Current Share PriceUS$143.48
52 Week HighUS$159.52
52 Week LowUS$110.74
Beta0.70
1 Month Change-8.57%
3 Month Change1.72%
1 Year Change11.51%
3 Year Change15.51%
5 Year Change43.44%
Change since IPO57,244.75%

Recent News & Updates

Recent updates

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Mar 21
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Mar 05
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Balchem: Potential Turnaround Is In The Price

Feb 21

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Jan 03
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Dec 19
Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Nov 20
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Oct 19
Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Sep 09
The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 22
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Jul 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

May 28
Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 12
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Mar 14
We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Jan 11
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Dec 29
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 13
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Nov 29
Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Sep 20
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Acquisitions And Cost Pressures Draw Attention

Sep 12

Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Sep 05
Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Balchem to acquire Cardinal Associates or Bergstrom Nutrition

Aug 30

Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Aug 22
Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Aug 08
Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Balchem Q2 2022 Earnings Preview

Jul 28

Balchem: On The M&A Road Again

Jun 28

Balchem: A New Growth Stage Is Just Beginning

Jun 02

Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

May 30
Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

May 18
Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

May 02
Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Mar 28
Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Feb 26
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Dec 23
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Nov 18
Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Sep 22
We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Aug 16
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Good Quarterly Performance Priced In

Aug 02

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 12
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

May 13
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem EPS beats by $0.03, beats on revenue

Apr 30

Balchem: All Eyes On M&A And Autism Drug

Apr 26

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Mar 14
Is Balchem (NASDAQ:BCPC) A Risky Investment?

How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?

Feb 27
How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?

Shareholder Returns

BCPCUS ChemicalsUS Market
7D-3.0%-2.9%-3.7%
1Y11.5%5.6%20.2%

Return vs Industry: BCPC exceeded the US Chemicals industry which returned 5.6% over the past year.

Return vs Market: BCPC underperformed the US Market which returned 20.2% over the past year.

Price Volatility

Is BCPC's price volatile compared to industry and market?
BCPC volatility
BCPC Average Weekly Movement3.2%
Chemicals Industry Average Movement5.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: BCPC has not had significant price volatility in the past 3 months.

Volatility Over Time: BCPC's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19671,302Ted Harriswww.balchem.com

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Balchem Corporation Fundamentals Summary

How do Balchem's earnings and revenue compare to its market cap?
BCPC fundamental statistics
Market capUS$4.63b
Earnings (TTM)US$108.54m
Revenue (TTM)US$922.44m

42.7x

P/E Ratio

5.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BCPC income statement (TTM)
RevenueUS$922.44m
Cost of RevenueUS$620.38m
Gross ProfitUS$302.06m
Other ExpensesUS$193.51m
EarningsUS$108.54m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 03, 2024

Earnings per share (EPS)3.36
Gross Margin32.75%
Net Profit Margin11.77%
Debt/Equity Ratio29.4%

How did BCPC perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

23%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.